| Trial of anifrolumab in active systemic lupus erythematosus EF Morand, R Furie, Y Tanaka, IN Bruce, AD Askanase, C Richez, ... New England Journal of Medicine 382 (3), 211-221, 2020 | 943 | 2020 |
| Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase … R Fleischmann, E Mysler, S Hall, AJ Kivitz, RJ Moots, Z Luo, R DeMasi, ... The Lancet 390 (10093), 457-468, 2017 | 467 | 2017 |
| Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological … D van der Heijde, JCC Wei, M Dougados, P Mease, A Deodhar, ... The Lancet 392 (10163), 2441-2451, 2018 | 350 | 2018 |
| Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: a systematic review CM Quiñonez-Flores, SA González-Chávez, D Del Río Nájera, ... BioMed research international 2016, 2016 | 302 | 2016 |
| Relation between adverse events associated with allopurinol and renal function in patients with gout J Vazquez-Mellado, EM Morales, C Pacheco-Tena, R Burgos-Vargas Annals of the rheumatic diseases 60 (10), 981-983, 2001 | 235 | 2001 |
| Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 230 | 2019 |
| Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial A Deodhar, D van der Heijde, LS Gensler, TH Kim, WP Maksymowych, ... The Lancet 395 (10217), 53-64, 2020 | 213 | 2020 |
| Trial of upadacitinib and adalimumab for psoriatic arthritis IB McInnes, JK Anderson, M Magrey, JF Merola, Y Liu, M Kishimoto, ... New England Journal of Medicine 384 (13), 1227-1239, 2021 | 197 | 2021 |
| VX‐509 (Decernotinib), an oral selective JAK‐3 inhibitor, in combination with methotrexate in patients with rheumatoid arthritis MC Genovese, RF van Vollenhoven, C Pacheco‐Tena, Y Zhang, ... Arthritis & Rheumatology 68 (1), 46-55, 2016 | 167 | 2016 |
| Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. M Stone, PR Fortin, C Pacheco-Tena, RD Inman The Journal of rheumatology 30 (10), 2112-2122, 2003 | 152 | 2003 |
| Juvenile-onset spondyloarthropathies R Burgos-Vargas, C Pacheco-Tena, J Vázquez-Mellado Rheumatic Disease Clinics of North America 23 (3), 569-598, 1997 | 150 | 1997 |
| A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies R Burgos-Vargas, J Vazquez-Mellado, C Pacheco-Tena, ... Annals of the rheumatic diseases 61 (10), 941-942, 2002 | 144 | 2002 |
| Hypoxia and its implications in rheumatoid arthritis CM Quiñonez-Flores, SA González-Chávez, C Pacheco-Tena Journal of biomedical science 23, 1-9, 2016 | 133 | 2016 |
| Effect of macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials D Khanna, CP Denton, PA Merkel, T Krieg, FO Le Brun, A Marr, ... Jama 315 (18), 1975-1988, 2016 | 124 | 2016 |
| Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies G Vargas-Alarcon, JD Londono, G Hernandez-Pacheco, R Gamboa, ... Annals of the rheumatic diseases 61 (1), 48-51, 2002 | 120 | 2002 |
| Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index … MH Cardiel, JD Londoño, E Gutiérrez, C Pacheco-Tena, ... Clinical and experimental rheumatology 21 (4), 451-458, 2003 | 100 | 2003 |
| Low grade radiographic sacroiliitis as prognostic factor in patients with undifferentiated spondyloarthritis fulfilling diagnostic criteria for ankylosing spondylitis … G Huerta-Sil, JC Casasola-Vargas, JD Londoño, R Rivas-Ruíz, J Chávez, ... Annals of the rheumatic diseases 65 (5), 642-646, 2006 | 95 | 2006 |
| Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies C Pacheco‐Tena, C Alvarado De La Barrera, Y Lopez‐Vidal, ... Rheumatology 40 (8), 920-927, 2001 | 90 | 2001 |
| A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. C Pacheco-Tena, R Burgos-Vargas, J Vazquez-Mellado, J Cazarin, ... The Journal of rheumatology 26 (6), 1338-1346, 1999 | 89 | 1999 |
| Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial … MA Stone, U Payne, C Schentag, P Rahman, C Pacheco-Tena, RD Inman Rheumatology 43 (2), 148-155, 2004 | 84 | 2004 |
Paul R. FortinProfessor of Medicine, Université LavalVerified email at crchudequebec.ulaval.ca
